Back to top

rsi: Archive

Zacks Equity Research

Down 19.4% in 4 Weeks, Here's Why MillerKnoll (MLKN) Looks Ripe for a Turnaround

MillerKnoll (MLKN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

MLKNPositive Net Change

Zacks Equity Research

Down 20.9% in 4 Weeks, Here's Why You Should You Buy the Dip in PLBY Group (PLBY)

PLBY Group (PLBY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PLBYPositive Net Change

Zacks Equity Research

Down 14.3% in 4 Weeks, Here's Why BioCryst (BCRX) Looks Ripe for a Turnaround

BioCryst (BCRX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BCRXPositive Net Change

Zacks Equity Research

Here's Why NMI Holdings (NMIH) is Poised for a Turnaround After Losing 8.8% in 4 Weeks

NMI Holdings (NMIH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NMIHPositive Net Change

Zacks Equity Research

Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)

Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

BSXPositive Net Change

Zacks Equity Research

After Plunging 10.4% in 4 Weeks, Here's Why the Trend Might Reverse for Hamilton Lane (HLNE)

Hamilton Lane (HLNE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HLNENegative Net Change

Zacks Equity Research

Here's Why Corteva, Inc. (CTVA) is Poised for a Turnaround After Losing 15% in 4 Weeks

Corteva, Inc. (CTVA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CTVANegative Net Change

Zacks Equity Research

After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for DocuSign (DOCU)

DocuSign (DOCU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

DOCUPositive Net Change

Zacks Equity Research

Down 10% in 4 Weeks, Here's Why OneMain (OMF) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for OneMain (OMF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

OMFPositive Net Change

Zacks Equity Research

Down 21.9% in 4 Weeks, Here's Why Stitch Fix (SFIX) Looks Ripe for a Turnaround

Stitch Fix (SFIX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SFIXPositive Net Change

Zacks Equity Research

Down 13.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Deckers (DECK)

Deckers (DECK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

DECKPositive Net Change

Zacks Equity Research

Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Rigel (RIGL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

RIGLNegative Net Change

Zacks Equity Research

Nasdaq (NDAQ) Loses 5.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Nasdaq (NDAQ) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NDAQPositive Net Change

Zacks Equity Research

The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The Oncology Institute (TOI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

TOINo Net Change

Zacks Equity Research

After Plunging 34.6% in 4 Weeks, Here's Why the Trend Might Reverse for LivePerson (LPSN)

LivePerson (LPSN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LPSNNegative Net Change

Zacks Equity Research

Sprouts Farmers (SFM) Loses 14.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Sprouts Farmers (SFM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SFMPositive Net Change

Zacks Equity Research

Down 19.8% in 4 Weeks, Here's Why Groupon (GRPN) Looks Ripe for a Turnaround

Groupon (GRPN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

GRPNNegative Net Change

Zacks Equity Research

Down 29.3% in 4 Weeks, Here's Why FiscalNote Holdings, Inc. (NOTE) Looks Ripe for a Turnaround

FiscalNote Holdings, Inc. (NOTE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

NOTEPositive Net Change

Zacks Equity Research

Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks

The heavy selling pressure might have exhausted for Sagimet Biosciences Inc. (SGMT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SGMTPositive Net Change

Zacks Equity Research

Down 10.3% in 4 Weeks, Here's Why Cheesecake Factory (CAKE) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Cheesecake Factory (CAKE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CAKEPositive Net Change

Zacks Equity Research

Down 11.9% in 4 Weeks, Here's Why Skillsoft (SKIL) Looks Ripe for a Turnaround

Skillsoft (SKIL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SKILPositive Net Change

Zacks Equity Research

Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Soleno Therapeutics (SLNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SLNONegative Net Change

Zacks Equity Research

After Plunging 8.9% in 4 Weeks, Here's Why the Trend Might Reverse for PSEG (PEG)

The heavy selling pressure might have exhausted for PSEG (PEG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PEGPositive Net Change

Zacks Equity Research

Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround

ELUTIA INC (ELUT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ELUTPositive Net Change

Zacks Equity Research

INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

INmune Bio (INMB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

INMBPositive Net Change